MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) began seeking approval for a $41 building project in Ireland to house the neurovascular unit it sold to Stryker Corp. (NYSE:SYK) earlier this year.
The 100,000 square foot facility will live on Boston Scientific’s Cork, Ireland, campus but will be operated by Stryker, and some 600 local BSX employees will transfer to the new facility when it’s ready.
Stryker picked up BSX’s neurovascular unit for $1.5 billion early this year, a price that analysts called a "pretty impressive valuation for an underperforming asset."
In August Boston Scientific set aside $37 million for research & development at another of its Irish facilities in Clonmel. The company landed in Ireland in 1994 and is now one of the country’s largest employers, with about 5,000 employees.
The med-tech leviathan has two start-up businesses it plans to move into the space left behind by the neurovascular unit, RTE News reported.
Merge launches medical image sharing network
CooperVision recalls millions of contact lenses
Heart disease declines in the U.S.
Heart disease in the U.S. declined about 10 percent between 2004 and 2006, with improvements for both men and women and across all ages and education groups, Heartwire reported.
Pediatric emergency psychiatric visits on the rise
The number of pediatric patients who needed psychiatric care in hospital emergency departments rose from 2.4 percent of visits in 1999 to 3 percent of visits in 2007, according to the American Academy of Pediatrics.